|
1
|
Hongo M, Nagasaki Y and Shoji T:
Epidemiology of esophageal cancer: Orient to occident. Effects of
chronology, geography and ethnicity. J Gastroenterol Hepatol.
24:729–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou SL and Wang LD: Circulating
microRNAs: Novel biomarkers for esophageal cancer. World J
Gastroenterol. 16:2348–2354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
David S and Meltzer SJ: MicroRNA
involvement in esophageal carcinogenesis. Curr Opin Pharmacol.
11:612–616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown LM, Hoover R, Silverman D, Baris D,
Hayes R, Swanson GM, Schoenberg J, Greenberg R, Liff J, Schwartz A,
et al: Excess incidence of squamous cell esophageal cancer among US
Black men: Role of social class and other risk factors. Am J
Epidemiol. 153:114–122. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: A fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jankowski JA and Odze RD: Biomarkers in
gastroenterology: Between hope and hype comes histopathology. Am J
Gastroenterol. 104:1093–1096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patnaik SK, Mallick R and Yendamuri S:
MicroRNAs and esophageal cancer. J Gastrointestinal Oncol. 1:55–63.
2010.
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang J, Zhang SY, Gao YM, Liu YF, Liu YB,
Zhao ZG and Yang K: MicroRNAs as oncogenes or tumour suppressors in
oesophageal cancer: Potential biomarkers and therapeutic targets.
Cell Prolif. 47:277–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei JS, Song YK, Durinck S, Chen QR, Cheuk
AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J and Khan J: The
MYCN oncogene is a direct target of miR-34a. Oncogene.
27:5204–5213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu X, Chen W, Miao R, Zhou Y, Wang Z,
Zhang L, Wan Y, Dong Y, Qu K and Liu C: miR-34a induces cellular
senescence via modulation of telomerase activity in human
hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Oncotarget. 6:3988–4004. 2015.PubMed/NCBI
|
|
14
|
Chen H, Zou Y, Yang H, Wang J and Pan H:
Downregulation of FoxM1 inhibits proliferation, invasion and
angiogenesis of HeLa cells in vitro and in vivo. Int J Oncol.
45:2355–2364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rice TW, Rusch VW, Apperson-Hansen C,
Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE,
et al: Worldwide esophageal cancer collaboration. Dis Esophagus.
22:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ogawa R, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Katada T, Harata K, Tanaka T and Fujii Y: Expression
profiling of micro-RNAs in human esophageal squamous cell carcinoma
using RTPCR. Med Mol Morphol. 42:102–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin X, Xu XY, Chen QS and Huang C:
Clinical significance of microRNA-34a in esophageal squamous cell
carcinoma. Genet Mol Res. 14:17684–17691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi H, Zhou S, Liu J, Zhu J, Xue J, Gu L
and Chen Y: miR-34a inhibits the in vitro cell proliferation and
migration in human esophageal cancer. Pathol Res Pract.
212:444–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao X, Huang X, Ye F, Chen B, Song C, Wen
J, Zhang Z, Zheng G, Tang H and Xie X: The miR-34a-LDHA axis
regulates glucose metabolism and tumor growth in breast cancer. Sci
Rep. 6:217352016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cathcart J, Pulkoski-Gross A and Cao J:
Targeting matrix metalloproteinases in cancer: Bringing new life to
old ideas. Genes Dis. 2:26–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye H, Kelly TF, Samadani U, Lim L, Rubio
S, Overdier DG, Roebuck KA and Costa RH: Hepatocyte nuclear factor
3/fork head homolog 11 is expressed in proliferating epithelial and
mesenchymal cells of embryonic and adult tissues. Mol Cell Biol.
17:1626–1641. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D,
Huang S, Tan D and Xie K: Critical role and regulation of
transcription factor FoxM1 in human gastric cancer angiogenesis and
progression. Cancer Res. 69:3501–3509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Monteiro LJ, Khongkow P, Kongsema M,
Morris JR, Man C, Weekes D, Koo CY, Gomes AR, Pinto PH, Varghese V,
et al: The Forkhead Box M1 protein regulates BRIP1 expression and
DNA damage repair in epirubicin treatment. Oncogene. 32:4634–4645.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schimmel J, Eifler K, Sigurðsson JO,
Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD,
Francavilla C, Medema RH, Olsen JV and Vertegaal AC: Uncovering
SUMOylation dynamics during cell-cycle progression reveals FoxM1 as
a key mitotic SUMO target protein. Mol Cell. 53:1053–1066. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Madureira PA, Varshochi R, Constantinidou
D, Francis RE, Coombes RC, Yao KM and Lam EW: The Forkhead box M1
protein regulates the transcription of the estrogen receptor alpha
in breast cancer cells. J Biol Chem. 281:25167–25176. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li D, Peng Z, Tang H, Wei P, Kong X, Yan
D, Huang F, Li Q, Le X, Li Q and Xie K: KLF4-mediated negative
regulation of IFITM3 expression plays a critical role in colon
cancer pathogenesis. Clin Cancer Res. 17:3558–3568. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zuo J, Zhu K, Wang Y and Yu Z:
MicroRNA-34a suppresses invasion and metastatic in esophageal
squamous cell carcinoma by regulating CD44. Mol Cell Biochem.
443:139–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nie J, Ge X, Geng Y, Cao H, Zhu W, Jiao Y,
Wu J, Zhou J and Cao J: miR-34a inhibits the migration and invasion
of esophageal squamous cell carcinoma by targeting Yin Yang-1.
Oncol Rep. 34:311–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song L, Wang X and Feng Z: Overexpression
of FOXM1 as a target for malignant progression of esophageal
squamous cell carcinoma. Oncol Lett. 15:5910–5914. 2018.PubMed/NCBI
|
|
33
|
Hui MK, Chan KW, Luk JM, Lee NP, Chung Y,
Cheung LC, Srivastava G, Tsao SW, Tang JC and Law S: Cytoplasmic
Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma
significantly correlates with pathological disease stage. World J
Surg. 36:90–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
